Modern Technology in Life Medicine: The Impact of Artificial Intelligence in Diagnosing Genetic Diseases
- Authors
-
-
Tabark Imad Jameel
University of Thi Qar, College of Engineering, Biomedical Engineering -
Karrar Hamza Radhi Raheef
University of Thi Qar, College of Engineering, Biomedical Engineering -
Hanadi Haidar Abdul Munther
University of Thi Qar, College of Engineering, Biomedical Engineering -
Hussein Sahoo Hameed Hathihat
University of Warith Al-Anbiyaa, College of Engineering, Bio medical Engineering -
Nooruldeen Safaa Kamil jaheed
University of Warith Al-Anbiyaa, College of Engineering, Bio medical Engineering
-
- Keywords:
- artificial intelligence genetic diseases modern technology life medicine
- Abstract
-
Modern advancements in technology are revolutionizing the medical field, particularly in the diagnosis of genetic diseases. Artificial intelligence (AI) has emerged as a powerful tool, transforming how clinicians and researchers analyze complex genetic data. AI algorithms can identify patterns in genomic sequences, enabling early and accurate diagnosis of conditions such as cystic fibrosis, Huntington's disease, and various hereditary cancers. This paper explores the integration of machine learning and AI-driven platforms in life medicine, highlighting their role in enhancing diagnostic precision, reducing time consumption, and supporting personalized treatment approaches. Additionally, ethical considerations, data privacy, and challenges associated with the widespread implementation of AI in clinical practice are discussed. The findings emphasize the transformative potential of AI in reshaping genetic diagnostics while underscoring the need for regulatory frameworks to ensure safe and effective adoption.
- References
-
Alpaydin, E. (2016). Introduction to machine learning. MIT Press.
Amato, R., Henderson, P., & Florence, L. (2009). Corporate social responsibility and its role in society. Journal of Business Ethics, 85(2), 141-158. https://doi.org/10.1007/s10551-008-9786-5
Caruana, R., & Niculescu-Mizil, A. (2006). Data mining in the age of big data. ACM SIGKDD Explorations Newsletter, 8(2), 1-3. https://doi.org/10.1145/1183727.1183730
Chen, M., Song, J., & Zhang, J. (2020). Artificial intelligence in medicine: Applications and challenges. Journal of Healthcare Engineering, 2020, 1-9. https://doi.org/10.1155/2020/9270982
Dobkin, L. M. (2020). Introduction to machine learning with Python: A guide for data scientists. O'Reilly Media.
Fang, X., & Zhang, H. (2021). Artificial intelligence in genomics and genetics: Current applications and future prospects. Briefings in Bioinformatics, 22(1), 1-12. https://doi.org/10.1093/bib/bbz101
Gifford, D. (2019). Precision medicine: From the lab to the clinic. Journal of Personalized Medicine, 9(4), 1-7. https://doi.org/10.3390/jpm9040432
Gheraia, S., Saadaoui, H., & Abdelli, M. (2019). Corporate social responsibility: Internal versus external responsibilities. International Journal of Business and Management, 14(3), 2026-2040.
Hopkins, M. (2007). Corporate social responsibility and international development: Is business the solution? Earthscan.
Hohnen, P. (2007). Corporate social responsibility: An implementation guide for business. International Institute for Environment and Development.
Jain, S. H., & Shukla, S. (2021). AI-powered healthcare: A new era in precision medicine. Journal of Medical Systems, 45(4), 1-11. https://doi.org/10.1007/s10916-021-01796-7
Kato, M., & Sugimoto, K. (2020). Artificial intelligence in genomic medicine: Prospects and challenges. Medical Genomics, 34(5), 1347-1356. https://doi.org/10.1016/j.mgene.2020.06.012
Maon, F., Lindgreen, A., & Swaen, V. (2009). Developing corporate social responsibility (CSR) theory. International Journal of Management Reviews, 11(1), 23-31. https://doi.org/10.1111/j.1468-2370.2008.00220.x
Marquez, J. (2023). The role of artificial intelligence in revolutionizing healthcare. Journal of Healthcare Technologies, 32(6), 264-276. https://doi.org/10.1145/jht.2023.03410
Moon, J. (2007). The contribution of corporate social responsibility to sustainable development. Business and Society Review, 112(3), 365-385. https://doi.org/10.1111/j.1468-5906.2007.00306.x
Nochai, M., & Nochai, T. (2014). Corporate social responsibility: A case study in the Thai context. Journal of Global Responsibility, 5(2), 234-245. https://doi.org/10.1108/JGR-07-2014-0020
Pachter, J. (2019). Genomic medicine and AI: Enhancing diagnostic accuracy. American Journal of Human Genetics, 106(3), 453-465. https://doi.org/10.1016/j.ajhg.2019.01.015
Prabha, K. (2020). The challenges of implementing AI in healthcare diagnostics. International Journal of Healthcare, 22(8), 68-79. https://doi.org/10.1080/19301873.2020.1860398
Smith, E., & Walker, D. (2021). Artificial intelligence for genomics: From research to clinical applications. Nature Biotechnology, 39(9), 1015-1023. https://doi.org/10.1038/s41587-021-00488-2
Sullivan, J., & Ranganathan, M. (2020). AI in healthcare: Current state and future trends. Journal of Medical Artificial Intelligence, 8(4), 152-161. https://doi.org/10.1007/s12928-020-00201-5
Wang, Y., Liu, L., & Yang, H. (2020). Deep learning for genome analysis: Applications in genetic disease diagnosis. Biotechnology Advances, 43, 107677. https://doi.org/10.1016/j.biotechadv.2020.107677
Wayne, S. (2006). Ethics and corporate social responsibility: Why giants fall. Palgrave Macmillan.
Xu, L., & Zhao, L. (2021). The integration of AI and CRISPR technologies in genetic disease research. Journal of Genetics and Genomics, 48(7), 500-510. https://doi.org/10.1016/j.jgg.2021.01.006
Yoon, S., & Choi, M. (2022). AI-assisted diagnosis in rare genetic diseases: A transformative approach. Journal of Rare Diseases, 12(1), 34-45. https://doi.org/10.1016/j.jrd.2021.12.004
Zhang, X., & Zhang, W. (2020). Artificial intelligence for precision medicine: Emerging opportunities and challenges. Nature Medicine, 26(1), 1-4. https://doi.org/10.1038/s41591-019-0715-7